Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/04/2003US20030224463 Using aberrant nucleotide sequence repair to diagnose and determine cancer predisposition
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224456 Identifying modulators which act on a signal transducer and activator of transcription (STAT) protein; for diagnosing and treating cancers
12/04/2003US20030224445 Using lipoprotein concentration of fat granules, urinary lipomicrons and oval fat to diagnosis kidney disorders
12/04/2003US20030224439 Multiplexed systems for nucleic acid sequencing
12/04/2003US20030224437 Discriminately identifying nucleic acid sequences of coliform bacteria; high throughput assay
12/04/2003US20030224436 Microfluidic apparatus and method for enriching and analyzing biological cells
12/04/2003US20030224435 Detection of abused substances and their metabolites using nucleic acid sensor molecules
12/04/2003US20030224434 Homogeneous real-time mutation scanning using denaturation/renaturation kinetics; restriction fragment length polymorphisms
12/04/2003US20030224428 Identifying compounds for treating blood, tumor, nervous system and autoimmune disorders
12/04/2003US20030224426 Human G-protein chemokine receptor HSATU68
12/04/2003US20030224423 Method of testing for allergic diseases
12/04/2003US20030224422 Pre-and post therapy gene expression profiling to identify drug targets
12/04/2003US20030224419 Data analysis and display system for ligation-based DNA sequencing
12/04/2003US20030224418 Using low serum high density lipoproteins to diagnose/prognose coronary artery disease and myocardial infarction
12/04/2003US20030224416 Diagnosing psychological disorders via detection of transcriptional variants in gene coding membrane proteins associated electrical potential; drug screening
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224412 Structurally biased random peptide libraries based on different scaffolds
12/04/2003US20030224411 Genes that are up- or down-regulated during differentiation of human embryonic stem cells
12/04/2003US20030224407 Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
12/04/2003US20030224403 Treating anthrax infection comprising administering/exposing cells to inhibitor of lethal toxin (LETX) and antibiotic and monitoring/evaluating toxin activity in cells
12/04/2003US20030224402 Progression suppressed gene 13 (PSGen 13) and uses thereof
12/04/2003US20030224401 Proteins for helicobacter diagnosis
12/04/2003US20030224399 Methods for determining the prognosis for patients with a prostate neoplastic condition
12/04/2003US20030224395 Methods and apparatus for performing submicroliter reactions with nucleic acids or proteins
12/04/2003US20030224394 Computer systems and methods for identifying genes and determining pathways associated with traits
12/04/2003US20030224393 Comprise nucleotide sequences coding prostaglandin E receptor for diagnosis and treatment or arteriosclerosis/cardiovascular diseases
12/04/2003US20030224390 Screening combinatorial peptide libraries for identifing amino acid sequences which bind and activate cellular processes; drug screening
12/04/2003US20030224389 Concurrently separating double and single stranded polynucleotide sequences present in mixture via absorption of nucleic acids to mineral support; in vitro transcription
12/04/2003US20030224388 RIP2: a mediator of signaling in the innate and adaptive immune systems
12/04/2003US20030224386 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/04/2003US20030224385 Targeted genetic risk-stratification using microarrays
12/04/2003US20030224383 Atherosclerotic phenotype determinative genes and methods for using the same
12/04/2003US20030224382 Measuring concentration of two or more nucleic acid molecules in target cell for use in diagnosing and treating cancer, autoimmune, infectious, aging, developmental, proliferative and neurological disorders
12/04/2003US20030224380 Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
12/04/2003US20030224379 Novel nucleic acids and polypeptides
12/04/2003US20030224377 Novel LNA compositions and uses thereof
12/04/2003US20030224376 Novel human transferase family members and uses thereof
12/04/2003US20030224375 Assays for evaluating the function of rna helicases
12/04/2003US20030224374 Classifying/diagnosing/prognosing tumorous condition via presence of estrogen receptor
12/04/2003US20030224372 Using short tandem repeats (STR) to identify hereditary background; forensics; genetic mapping
12/04/2003US20030224371 Integrated cartridge for sample manipulation
12/04/2003US20030224370 Method and apparatus for recognizing molecular compounds
12/04/2003US20030224368 Crystallizable compositions comprising a caspase-7
12/04/2003US20030224367 Novel polypeptides and nucleic acids encoding same
12/04/2003US20030224366 Spherical glass surface composed of magnetic particles for the purification of biological materials; immunoassay; affinity chromatography
12/04/2003US20030224365 Single nucleotide polymorphisms diagnostic for schizophrenia
12/04/2003US20030224362 Diagnosing alcoholism using presence of mutation in neuropeptide y gene; drug abuse; restriction fragment length polymorphisms; immunoassay
12/04/2003US20030224361 Method of making random array of microspheres using enzyme digestion
12/04/2003US20030224360 Interventions to mimic the effects of calorie restriction
12/04/2003US20030224359 Tmleveling methods
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224357 Using computer models to improve and analyze binding characteristics of DNA; designing microarrays, primers and oligonucleotide for genetic analysis
12/04/2003US20030224356 Single copy genomic hybridization probes and method of generating same
12/04/2003US20030224355 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (alpha), HNF-1beta and HNF-4alpha
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224351 Detection of infectious hematopoietic necrosis virus
12/04/2003US20030224350 Elimination of endogenous porcine retrovirus
12/04/2003US20030224348 Methods of screening for SCAP antagonists
12/04/2003US20030224347 Pharmaceutical compositions
12/04/2003US20030224345 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
12/04/2003US20030224344 Method and system for clustering data
12/04/2003US20030224055 Compositions and processes for inhibiting gene expression using polynucleotides
12/04/2003US20030224040 Genomic screen for epigenetically silenced genes associated with cancer
12/04/2003US20030224015 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223991 Modulating activity of the immune system using agonists or antagonists of a CD200 receptor. Also provided are methods of treatment and diagnosis of immune disorders.
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003US20030223986 Methods
12/04/2003US20030223981 Peptide inhibitors of protein kinase C gamma for pain management
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030223972 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/04/2003US20030223959 Diagnosis, monitoring, and treatment of multiple sclerosis. The invention is based in part on the discovery that Chlamydia is present in patients with multiple sclerosis, and that anti-chlamydial agents improve or sustain neurological
12/04/2003US20030223911 Identically shaped spots can be formed sequentially and stably by a spotting pin comprising a bar-like plunger 20. Four projections each formed in the shape of a top portion of a quadrangular pyramid are formed on the head of the plunger
12/04/2003CA2525976A1 Modulation of ptp1b signal transduction by rna interference
12/04/2003CA2494134A1 Treatment for diabetes
12/04/2003CA2487322A1 Animal genotyping method
12/04/2003CA2487303A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2487106A1 Protein c polymorphisms
12/04/2003CA2487093A1 Microarrays and method for running hybridization reaction for multiple samples on a single microarray
12/04/2003CA2487006A1 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
12/04/2003CA2486685A1 Method and apparatus for measuring white blood cell count
12/04/2003CA2486619A1 Methods and materials for treating inflammatory conditions
12/04/2003CA2486618A1 Methods for the in vitro culture of sporozoea sp. and uses thereof
12/04/2003CA2486578A1 Detection of secreted polypeptides
12/04/2003CA2486431A1 Computer systems and methods for subdividing a complex disease into component diseases
12/04/2003CA2486410A1 Fluorescence polarization detection of nucleic acids
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003CA2486218A1 Method for identifying type-i interferon responsive ms patients by determining trail expression
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2485988A1 Methods of modulating tubulin deacetylase activity
12/04/2003CA2485825A1 Method for identification of a ligand whereby receptor residence time is measured
12/04/2003CA2485648A1 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003CA2485184A1 Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
1 ... 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 ... 3003